Pharmafile Logo

Webcast: The virtual patient: How to use AI-powered conjoint to understand complex treatment decisions

January 13, 2023 | AI, Quant, Virtual, digital health 

Watch to find out how a combination of virtual patients and artificial intelligence can help you to better understand physicians’ decision making processes.

- PMLiVE

The virtual patient: How to use AI-powered conjoint to understand complex treatment decisions

Small populations and even smaller sample sizes are a common problem when conducting healthcare market research, particularly within rare diseases. Could virtual patients help us to plug the gaps and determine how physicians might treat their patients in a clinical setting?

In the webcast, we demonstrate how a combination of virtual patients and artificial intelligence can help you to better understand physicians’ decision making processes. Using a series of real-life case studies, quantitative experts Richard Goosey and Will Tolley outline how we’ve been helping pharmaceutical companies to determine which patient attributes are driving treatment choices, which segments they should be targeting, and the likely demand for their product profiles using the latest technologies and advanced analytical techniques.

What are the takeaways?

  • Learn how virtual patients could help you to better understand treatment decisions
  • Discover how AI-powered conjoint can provide you with more actionable data
  • Find out how Research Partnership can help you to better predict what might happen using AI
  • Pick up practical tips for conducting conjoint in a range of small sample settings

Watch here

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Will gene therapies finally be commercially viable to pharma?

Our latest Free Thinking white paper explores the science behind the idea of gene therapy and takes a look at some of the core challenges medical researchers have faced when...

Wargaming in HCV

The challenge:Our client had a product ready for launch in the HCV landscape. A number of new competitor products were expected to alter the market dynamics. Given the stage of...

Living with Lupus: Breaking the Silence

Published in eyeforpharma July 2017 by Mariel Metcalfe

Demystifying human-centred design: the application of iterative, human-centric approaches in global health market research

One of the biggest buzz topics in the global health community over the last couple of years has been human-centred design, also referred to as behaviour-centred design. In this blog...

In the news: What will the UK’s recent general election result and ongoing Brexit negotiations mean for DfID funding for global health?

The UK’s Department for International Development (DfID) was established in 1997 with a mandate to tackle world poverty. Since its inception, it has played a major role in the global...

EphMRA 2017 round up

We were delighted to present, exhibit and sponsor this year’s EphMRA Annual Conference in Amsterdam, Netherlands.

Taking a hybrid qualitative-quantitative approach to research

Directors Phil Rosenberg and Chris Gaj discuss ways to achieve qualitative insights with quantitative precision and the benefits of a hybrid approach.Watch the video: https://www.researchpartnership.com/news/2017/06/video-taking-a-hybrid-qualitative-quantitative-appr...

20th anniversary celebrations

We recently celebrated our 20th year anniversary with parties for our employees across the globe.Find out more and view the photos https://www.researchpartnership.com/news/2017/06/20th-anniversary-party-photos/

Pharma CI Asia Conference & Exhibition 2017

13-14 July 2017, Singapore

Director Richard Head is joint winner of the 2017 EphMRA President’s Award

We are delighted to announce that Research Partnership’s Richard Head is joint winner of the 2017 EphMRA President's Award for his contribution to pharmaceutical market research